BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clowse ME. The use of anti-TNFα medications for rheumatologic disease in pregnancy. Int J Womens Health 2010;2:199-209. [PMID: 21072312 DOI: 10.2147/ijwh.s6029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Santolaya JL, Kugler L, Francois L, Stefano VD, Ebert GA, Wolf R, Wang B, Santolaya-Forgas J. Baseline TNFα operational capacity in fetal and maternal circulation prior to the onset of labor: "tuned for different purposes". Reprod Sci 2013;20:838-44. [PMID: 23287097 DOI: 10.1177/1933719112468953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Geldhof A, Slater J, Clark M, Chandran U, Coppola D. Exposure to Infliximab During Pregnancy: Post-Marketing Experience. Drug Saf 2020;43:147-61. [PMID: 31677004 DOI: 10.1007/s40264-019-00881-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
3 Wei JC, Liu CH, Tseng JC, Hsieh LF, Chen CH, Chen HH, Chen HA, Chen YC, Chou CT, Liao HT, Lin YC, Luo SF, Yang DH, Yeo KJ, Tsai WC; Taiwan Rheumatology Association (TRA). Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis. Int J Rheum Dis 2020;23:7-23. [PMID: 31777200 DOI: 10.1111/1756-185X.13752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Porter ML, Lockwood SJ, Kimball AB. Update on biologic safety for patients with psoriasis during pregnancy. Int J Womens Dermatol 2017;3:21-5. [PMID: 28492050 DOI: 10.1016/j.ijwd.2016.12.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]